Eisai Posts First Ever Net Loss Due To Heavy Investment
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Eisai posted losses in net income for fiscal 2007 due to heavy investment in oncology research and development through recent acquisitions. Eisai's losses were a first since it became a listed company in 1961